The customer reported obtaining a non-reproducible creatine kinase m sub-unit/b sub-unit (access ck-mb) result involving the unicel dxi 800 access immunoassay system serial number (b)(4) for one (1) patient.The patient's sample was reanalyzed on the same unicel dxi 800 access immunoassay system and a lower result, within the laboratory's normal reference range, was obtained.The elevated access ck-mb result was released from the laboratory.There was a report of a change in patient treatment as the customer stated that the patient was admitted to the hospital in association with the elevated access ck-mb result.Quality control (qc), calibration, precision, and system check were performing within assay and instrument specifications at the time of the event.The sample was serum, collected in a serum separator gel tube.The sample was centrifuged on the automation line for six (6) minutes at 30,000 rpm (revolutions per minute).The customer indicated the sample contained fibrin.
|
There is no indication the access ck-mb reagent was returned for evaluation.A beckman coulter (bec) field service engineer (fse) was not dispatched.System parameters of quality control (qc), calibration, precision, and system check were performing within assay and instrument specifications.In conclusion, the cause of the event was pre-analytical sample handling as the sample contained fibrin.(b)(4).
|